ANKET

Welcome to the Brand page for “ANKET”, which is offered here for Pharmaceuticals, medical, biological or biochemical preparations, substances for the treatment of diseases, as well as preparations for medical treatments, in particular, antibodies and derivatives being monoclonal antibodies, bispecific antibodies, multispecific antibodies, antibody fragments, single-chain variable fragments, di-scfv or light and heavy chains of antibodies for medical purposes, bifunctional or multifunctional proteins being t-cell engagers or nk cell engagers for medical purposes with binding affinity to immune cells, in particular nk cells, and other reagents for the diagnosis, prevention, monitoring and treatment of diseases, in particular cancers, infectious diseases, inflammatory diseases, and other immune pathologies;chemical or biotechnological products for industry and science, polypeptides and proteins; biological preparations, in particular antibodies in the nature of monoclonal antibodies, bispecific antibodies or multifunctional antibodies, antibody derivatives in the nature of antibody fragments, single-chain variable fragments, di-scfv, light and heavy chains of antibodies, binding proteins and peptides having a binding affinity to immune cells in the nature of t-cell engagers or nk-cell engagers, for laboratory and experimental purposes, in particular for conducting experimental tests other than for medical use; biochemicals, polypeptides for in vitro research use;scientific and technological services, research and development in scientific and medical matters, in particular in the field of immunotherapy; scientific and technological services, scientific research and development related to diagnostic products; pharmaceutical and biotechnological scientific laboratory services; laboratory research, analysis, evaluation, development and clinical trial of therapeutic compositions and treatments in the field of oncology; all of the above services concerning the use of antibodies, antibody derivatives, proteins, or other agents for activating or modulating natural and adaptive immunity;.

Its status is currently believed to be active. Its class is unavailable. “ANKET” is believed to be currently owned by “INNATE PHARMA”.

Owner:
INNATE PHARMA
Owner Details
Description:
Pharmaceuticals, medical, biological or biochemical preparations, substances for the treatment of diseases, as well as preparations for medical treatments, in particular, antibodies and derivatives being monoclonal antibodies, bispecific antibodies, multispecific antibodies, antibody fragments, single-chain variable fragments, di-scFv or light and heavy chains of antibodies for medical purposes, bifunctional or multifunctional proteins being T-cell engagers or NK cell engagers for medical purposes with binding affinity to immune cells, in particular NK cells, and other reagents for the diagnosis, prevention, monitoring and treatment of diseases, in particular cancers, infectious diseases, inflammatory diseases, and other immune pathologies;Chemical or biotechnological products for industry and science, polypeptides and proteins; biological preparations, in particular antibodies in the nature of monoclonal antibodies, bispecific antibodies or multifunctional antibodies, antibody derivatives in the nature of antibody fragments, single-chain variable fragments, di-scFv, light and heavy chains of antibodies, binding proteins and peptides having a binding affinity to immune cells in the nature of T-cell engagers or NK-cell engagers, for laboratory and experimental purposes, in particular for conducting experimental tests other than for medical use; Biochemicals, polypeptides for in vitro research use;Scientific and technological services, research and development in scientific and medical matters, in particular in the field of immunotherapy; scientific and technological services, scientific research and development related to diagnostic products; pharmaceutical and biotechnological scientific laboratory services; laboratory research, analysis, evaluation, development and clinical trial of therapeutic compositions and treatments in the field of oncology; all of the above services concerning the use of antibodies, antibody derivatives, proteins, or other agents for activating or modulating natural and adaptive immunity;
Categories: PHARMACEUTICALS